This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Hub and Specialty Pharmacy Models East 2025

Last Chance to Save:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Andrew Satterlee, PhD
Assistant Professor, Director of the Screening Live Cancer Explants Program at University of North Carolina at Chapel Hill
Speaker

Profile

Andrew Satterlee, PhD, is an Assistant Professor and Founding Director of the Screening Live Cancer Explants Program and Core Facility based within Eshelman Innovation, an academic innovation institute at UNC focused on translating groundbreaking ideas toward patients. Dr. Satterlee is himself a pediatric brain cancer survivor whose rare, heterogeneous tumor lacked a clear treatment strategy. Today, his program focuses on developing functional precision medicine models that directly treat living patient tumor tissues outside the body just after they have been removed in the operating room to guide drug development and clinical decision-making.

Agenda Sessions

  • Leveraging the Patient Voice to Advance Collaboration and Partnership

    1:15pm